THE DEAL, AT A GLANCE
From the announcementHopstem
01Who is involvedBacked by stroke, traumatic brain injuryFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedHopstem raised Series C, announced 2026-08-10From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersHopstem’s Series C first closing supports continued development of an iPSC-derived forebrain neural cell therapy, with the stated focus on accelerating work tied to…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Hopstem · Financing Record
Explore source-linked visual explanations for Hopstem. Unsupported claims are withheld while source review continues.
Record 9939 · Recorded date: 2026-08-10
Explore company records →